Tivantinib Uses, Dosage, Side Effects and more
Tivantinib has been investigated in Solid Tumors.
| Trade Name | Tivantinib |
| Generic | Tivantinib |
| Tivantinib Other Names | Tivantinib |
| Type | |
| Formula | C23H19N3O2 |
| Weight | Average: 369.424 Monoisotopic: 369.147726864 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Tivantinib works
Tivantinib mediates its effects by inhibiting the activity of c-Met, a receptor tyrosine kinase that plays multiple key roles in human cancer, including cancer cell growth, survival, angiogenesis, invasion and metastasis. C-Met is abnormally activated in most cancers and is believed to control multiple signal transduction pathways involved in tumor growth and metastasis.
